🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The study is to evaluate immune response induced by 9-valent HPV study vacc...
Status
Active Not Recruiting
Location
Yunnan Center for Disease Prevention and Control
Start Date
2022-03-23
Trial ID
NCT05662020
Primary Objective: To demonstrate the non-inferiority of the seroprotectio...
Status
Completed
Location
Investigational Site Number :3480003
Start Date
2021-03-16
Trial ID
NCT04490018
Treatments Being Tested
The purposes of this phase 3, double-blind, placebo-controlled clinical stu...
Status
Completed
Location
Umeyama Clinic ( Site 6406)
Start Date
2020-11-30
Trial ID
NCT04635423
This randomized controlled trial will evaluate a bivalent HPV vaccine, Ceco...
Status
Completed
Location
International Centre for Diarrhoeal Disease Research
Start Date
2021-03-15
Trial ID
NCT04508309
Patients who undergo allogeneic stem cell transplantation lose previously a...
Status
Recruiting
Location
Skåne's University Hospital
Start Date
2025-05-12
Trial ID
NCT06793410
This study will evaluate the immunogenicity and safety of Zerun 9-valent HP...
Status
Unknown
Location
GuangXi Center for Diseases Control and Prevention
Start Date
2022-09-01
Trial ID
NCT05580341
Treatments Being Tested
This Study to Evaluate the Immunogenicity and Safety of Candidate Recombina...
Status
Unknown
Location
University of Muhammadiyah Malang Hospital
Start Date
2023-11-21
Trial ID
NCT06207175
Treatments Being Tested
The risk for Human Papillomavirus (HPV) infection persists through an indiv...
Status
Completed
Location
Phrd-Ccr-Kemri
Start Date
2022-05-25
Trial ID
NCT05435209
Treatments Being Tested
Researchers are looking for new ways to prevent cancers related to human pa...
Status
Active Not Recruiting
Location
Anaheim Clinical Trials ( Site 0002)
Start Date
2024-11-12
Trial ID
NCT06623409
Treatments Being Tested
This study will assess the safety and immunogenicity of GARDASIL®9 (V503) i...
Status
Completed
Location
Universitatsklinik fuer Frauenheilkunde und Geburtshilfe ( Site 0002)
Start Date
2017-09-20
Trial ID
NCT03158220
Treatments Being Tested